Polyvinylpyrrolidones (PVP) Market

Polyvinylpyrrolidones (PVP) Market Analysis and Forecast by Fact.MR

• The Polyvinylpyrrolidones (PVP) Market is expected to grow from USD 3.3 billion in 2026 to USD 6.3 billion by 2036, at a 6.6% CAGR.
• Driven by rising pharmaceutical manufacturing demand for PVP tablet binders and film coatings, expanding cosmetic industry adoption for hair fixative and skin care formulations, and growing industrial applications as dispersant and stabilizer in coatings and adhesive systems, with pharmaceutical grade PVP accounting for 34.6% share
• Pharmaceutical formulations contributing 44.2% share as companies invest in high-purity excipient production, copolymer development, and solubility enhancement technologies.

Summary of Polyvinylpyrrolidones (PVP) Market

• Market Snapshot
  • In 2025, the global Polyvinylpyrrolidones (PVP) Market was valued at approximately USD 3.1 billion.
  • The market is estimated to reach USD 3.3 billion in 2026 and is projected to attain USD 6.3 billion by 2036.
  • The polyvinylpyrrolidones (pvp) market is likely to expand at a CAGR of 6.6% during the forecast period.
  • The market is anticipated to create an absolute dollar opportunity of USD 3 billion between 2026 and 2036.
  • Pharmaceutical Grade Polyvinylpyrrolidone accounts for 34.6% of product segment share in 2026.
  • China (6.4%) and U.S. (5.8%) are the key growth markets during the forecast period.
• Demand and Growth Drivers
  • Global expansion in pharmaceutical tablet manufacturing is driving demand for PVP as the leading polymeric binder and film-forming excipient in oral solid dosage formulations.
  • The non-pharmaceutical demand base is expanding with the cosmetic and personal care industry increasing the use of PVP and VP copolymers in hair styling fixatives, skin care film formers, and color cosmetic binders.
  • Additional volume demand comes from applications of PVP as dispersant, protective colloid and film-forming agent in industrial coatings and adhesives.
  • Growth of generic drug manufacturing in emerging markets is driving proportional demand for excipients including pharmaceutical-grade PVP for production of tablets.
  • Formulations for improving the solubility of poorly water-soluble drug compounds with PVP are a high-value pharmaceutical application channel.
• Product and Segment View
  • Pharmaceutical grade PVP is leading the industry with a product share of 34.6% in 2026 due to its proven excipient status and wide application in tablet manufacturing.
  • Medium molecular weight PVP has the molecular weight class share of 39.8% due to its versatile binding and film-forming performance required in pharmaceutical and cosmetic formulations.
  • Key segmentation includes:
    • Product Pharmaceutical Grade PVP Cosmetic Grade PVP Industrial Grade PVP Food Grade PVP
    • Application: Pharmaceutical Formulations, Personal Care Products, Industrial Coatings & Adhesives, Food & Beverage
    • PVP Types: Powder PVP, Liquid PVP Solutions, PVP Copolymers
  • These polymers enable:
    • Pharmaceutical manufacturing of solid dosage: tablet binding and film coating
    • Hair fixation, skin film formation and pigment dispersion in cosmetic formulations
    • Dispersion stabilization and protective colloid action in industrial coatings and adhesives
• Geography and Competitive Outlook
  • China leads the way at 6.4%, driven by growth in the manufacturing of pharmaceuticals and cosmetics and domestic PVP production capacity.
  • U.S. 5.8% driven by strong demand from pharmaceutical excipient, cosmetic industry consumption and established PVP supply infrastructure.
  • South Korea 5.7% driven by growth in cosmetics industry and pharmaceutical manufacturing.
  • Key players Ashland BASF SE Boai NKY Nanhang Industrial
• Analyst Opinion
  • Shambhu Nath Jha, Principal Consultant at Fact.MR, says "The polyvinylpyrrolidones market is a specialty polymer segment where pharmaceutical excipient demand drives the highest-value applications. Ashland leads with 12% market share through its Plasdone and PVP K-series product portfolio, which holds validated excipient status across major pharmacopeias. BASF competes through its Kollidon portfolio with strong European pharmaceutical customer relationships. The growth opportunity is expanding as solubility enhancement formulations using PVP for poorly water-soluble drug compounds become a standard pharmaceutical development approach, creating premium demand beyond basic tablet binding applications."

Key Growth Drivers, Constraints, and Opportunities

Key Factors Driving Growth

• The need for validated PVP excipient grades is creating an in proportion demand due to the growth of pharmaceutical solid dosage manufacturing, especially generic drugs in India and China.
• PVP for amorphous solid dispersions in solubility enhancement applications are opening a high value pharmaceutical development channel.
• The cosmetic industry is increasingly turning to proven, skin-safe film formers like PVP and VP copolymer to keep up with K-beauty and clean beauty trends.

Key Market Constraints

• Established pharmaceutical and industrial grade manufacturers are under margin pressure from commodity pricing pressure exerted by Chinese PVP producers.
• Regulatory qualification timelines are barriers to competitive switching from new PVP excipient sources for pharmaceutical applications.
• The cost fluctuation of raw material N-vinyl-2-pyrrolidone monomer affects economics of PVP production and price stability.

Key Opportunity Areas

• The pharmaceutical application with the highest growth using amorphous solid dispersion technology with PVP to improve the bioavailability of poorly soluble drugs.
• The growing trend towards film-forming polymers in personal care, for long-wear cosmetics and skin care, is driving demand for cosmetic-grade PVP and copolymers.
• Specialty industrial applications in electronics, membranes and nanoparticle stabilization – niche high value demand channels

Segment-wise Analysis of the Polyvinylpyrrolidones (PVP) Market

• Pharmaceutical grade PVP is projected to account for 34.6% of product share in 2026, which reflects the demand for validated excipients.
• Pharmaceutical formulations are the leading application, accounting for 44.2% of the demand for tablet binder and film coating.
• Pharmaceutical companies account for 47.3% of end-use demand in 2026.

The market is segmented by product, molecular weight, application, form, end use and region. Pharmaceutical grade leads on validated excipient demand, with industrial grade growing on coating and adhesive applications. Powder PVP accounts for 42.1% of the form share.

Which Product Segment Dominates the PVP Market?

Pharmaceutical grade PVP will account for 34.6% of the product segment value by 2026. This segment is anchored by Ashland Plasdone and BASF Kollidon product lines through validated excipient status in USP, EP and JP pharmacopeias, with documented binding, film-forming and solubility enhancement performance.

Cosmetic grade PVP is used in personal care formulations where film forming and fixative properties are desired. Industrial grade PVP meets the needs of coatings, adhesives and textile processing applications where dispersant and stabilizer functionality is the predominant purchasing decision.

Which Application Segment Dominates the PVP Market?

Pharmaceutical formulations segment is estimated to account for 44.2% of application segment value in 2026. The maximum value PVP consumption in pharmaceutical manufacturing operations is for tablet wet granulation binding, film coating and amorphous solid dispersion preparation.

The second biggest application is in personal care products where cosmetic grade PVP and VP copolymers are used in hair fixative sprays, styling gels and skin care film formers. Other demand avenues include industrial coatings and food applications.

Which Product Trend is Shaping the Next Phase of Growth in the Polyvinylpyrrolidones (PVP) Market?

The primary pharma product trend driving PVP premium demand is the use of PVP-based amorphous solid dispersions to improve the solubility of poorly water-soluble drugs. Due to the increasing number of new drug candidates with poor aqueous solubility, PVP and copovidone (PVP-VA) are used by pharmaceutical formulators as a basis for stable amorphous solid dispersions to improve oral bioavailability.

This trend is supported by the industry’s shift toward hot-melt extrusion and spray-dried dispersion manufacturing technologies using PVP as the primary carrier polymer. Companies offering validated pharmaceutical grade PVP with documented stability, processability and bioavailability enhancement data for specific drug compound classes are capturing specification driven procurement decisions.

Regional Outlook Across Key Markets

• China leads with 6.4% due to the expansion of pharmaceutical and cosmetic manufacturing and domestic production of PVP .
• U.S. at 5.8% indicates robust pharmaceutical excipient demand and cosmetic demand.
• South Korea: 5.7% Cosmetic industry growth and pharmaceutical manufacturing support South Korea.

CAGR Table

Source: Fact.MR analysis, based on proprietary forecasting model and primary research.

China Polyvinylpyrrolidones (PVP) Demand Trends

The China Polyvinylpyrrolidones (PVP) Market is projected to grow at a CAGR of 6.4% through 2036. Domestic pharmaceutical manufacturing expansion and e-commerce-driven cosmetic industry growth create parallel demand channels for PVP across multiple grades. Domestic producers including Boai NKY offer competitive pricing against international suppliers.

• Domestic pharmaceutical manufacturing growth generates proportional demand for PVP excipient grades across tablet production.
• Cosmetic industry expansion driven by e-commerce and domestic brand development creates growing PVP demand for film-forming applications.
• Domestic PVP manufacturers offer competitive pricing, creating cost pressure for international suppliers in the Chinese market.

Polyvinylpyrrolidones (PVP) Growth Assessment in U.S.

The U.S. Polyvinylpyrrolidones (PVP) Market is projected to grow at a CAGR of 5.8% through 2036. FDA excipient qualification requirements and the established pharmaceutical manufacturing base shape PVP procurement. Sustainability mandates from cosmetic and personal care companies influence polymer sourcing decisions.

• FDA excipient qualification and DMF documentation requirements shape pharmaceutical-grade PVP procurement specifications.
• Cosmetic industry clean beauty and sustainability trends influence PVP copolymer selection for personal care formulations.
• Amorphous solid dispersion development for poorly soluble drugs generates premium demand for validated PVP excipient grades.

South Korea Polyvinylpyrrolidones (PVP) Market Growth Outlook

The South Korea Polyvinylpyrrolidones (PVP) Market is projected to grow at a CAGR of 5.7% through 2036. K-beauty cosmetic industry growth and pharmaceutical manufacturing create dual demand channels. Quality certification and formulation validation requirements shape PVP grade selection and supplier qualification.

• K-beauty industry growth generates sustained demand for cosmetic-grade PVP film formers and fixative copolymers.
• Pharmaceutical manufacturing quality standards shape excipient procurement toward validated PVP suppliers.
• Cosmetic innovation culture supports rapid adoption of new PVP copolymer grades for emerging beauty product categories.

Polyvinylpyrrolidones (PVP) Growth Assessment in Germany

The Germany Polyvinylpyrrolidones (PVP) Market is projected to grow at a CAGR of 5.5% through 2036. EU pharmaceutical manufacturing and cosmetic regulation compliance shape PVP grade requirements. BASF Kollidon production at Ludwigshafen provides domestic supply of validated pharmaceutical-grade PVP.

• EU pharmaceutical GMP requirements and pharmacopeia compliance shape PVP excipient procurement standards.
• BASF Kollidon domestic production provides validated pharmaceutical PVP supply to European formulators.
• EU cosmetic regulation compliance influences PVP grade selection for personal care product manufacturing.

Market Outlook for Polyvinylpyrrolidones (PVP) in India

The India Polyvinylpyrrolidones (PVP) Market is projected to grow at a CAGR of 5.3% through 2036. Ayushman Bharat and expanding generic pharmaceutical manufacturing drive PVP excipient demand. Domestic cosmetic industry growth and tier-2 city distribution create additional demand channels.

• Generic pharmaceutical manufacturing expansion generates growing demand for cost-effective PVP tablet binder excipients.
• Ayushman Bharat coverage expansion supports drug manufacturing volume that generates proportional excipient consumption.
• Domestic cosmetic industry growth in personal care and hair care creates demand for cosmetic-grade PVP products.

Competitive Benchmarking and Company Positioning

Polyvinylpyrrolidones (PVP) Market Analysis By Company

• Ashland leads with approximately 12.0% market share through its Plasdone and PVP K-series pharmaceutical excipient portfolio, established pharmacopeia validation, and global excipient distribution network.
• BASF SE competes through its Kollidon PVP and copovidone portfolio, strong European pharmaceutical customer relationships, and integrated polymer manufacturing capabilities.
• Boai NKY and Nanhang Industrial serve the market through large-scale Chinese PVP production, offering competitive pricing across pharmaceutical, cosmetic, and industrial grade segments.

The competitive landscape is moderately concentrated between Ashland and BASF in the premium pharmaceutical segment, with Chinese producers controlling a growing share of industrial and cost-sensitive grades. Ashland Plasdone products are the reference standard for pharmaceutical PVP excipients globally.

BASF competes through its integrated Verbund manufacturing approach and Kollidon brand recognition among European pharmaceutical formulators. Competition is shaped by excipient validation documentation, pharmacopoeia compliance, and the ability to provide formulation development support for solubility enhancement applications.

Key Companies in the Polyvinylpyrrolidones (PVP) Market

• Ashland, BASF SE, Boai NKY, Nanhang Industrial Co. Ltd., Nippon Shokubai, Shanghai Yuking Water Soluble Material Tech Co., Ltd., JH Nanhang Life Sciences, Zhangzhou Huafu Chemical Co., Ltd. are the leading companies.

Recent Industry Developments

• Ashland - Pharmaceutical PVP Excipient Portfolio Expansion (2025)
  • Ashland continued expanding its Plasdone PVP and copovidone excipient portfolio, supporting pharmaceutical industry demand for validated tablet binders and solubility enhancement carrier polymers across solid dosage manufacturing operations.
• BASF SE - Kollidon PVP and Biomass Balance Polymer Development (2025)
  • BASF maintained its Kollidon pharmaceutical PVP portfolio while advancing biomass balance polymer production approaches, addressing growing pharmaceutical and cosmetic customer demand for sustainably sourced excipient ingredients.
• Boai NKY - PVP Production Capacity Expansion in China (2025)
  • Boai NKY continued expanding PVP production capacity at its Chinese manufacturing facilities, supporting growing domestic and export demand for pharmaceutical, cosmetic, and industrial grade polyvinylpyrrolidone products.

Leading Companies Shaping the Polyvinylpyrrolidones (PVP) Market

• Ashland
• BASF SE
• Boai NKY
• Nanhang Industrial Co. Ltd.
• Nippon Shokubai
• Shanghai Yuking Water Soluble Material Tech Co., Ltd.
• JH Nanhang Life Sciences
• Zhangzhou Huafu Chemical Co., Ltd.

Sources and Research References

• Ashland Inc. (2025). Plasdone™ povidone and copovidone excipients for pharmaceutical applications. Ashland Pharmaceuticals.
• BASF SE. (2025). Kollidon® pharmaceutical excipients and biomass balance approach for sustainable polymer production. BASF Pharma Solutions. h
• Boai NKY Pharmaceuticals Ltd. (2025). Polyvinylpyrrolidone (PVP) manufacturing capabilities and production expansion initiatives. Boai NKY Pharmaceuticals Ltd.

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations.

Key Questions This Report Addresses

• What is the estimated size of the global PVP Market in 2026, and how is it projected to grow through 2036?
• What incremental revenue opportunity is the market expected to create between 2026 and 2036?
• Which product segment holds the largest share in 2026, and what excipient validation factors support pharmaceutical grade leadership?
• How is the balance between pharmaceutical and cosmetic grade PVP expected to shift?
• Which application is projected to generate the most incremental revenue through 2036?
• Which countries are projected to register the highest CAGR, and what pharmaceutical manufacturing factors accelerate growth?
• How do demand patterns in China compare with the U.S. and Germany in terms of grade requirements and pricing dynamics?
• What raw material costs and Chinese producer competition could affect pricing dynamics?
• Who are the leading companies, and how are they differentiating through excipient validation, portfolio breadth, and formulation support?
• What recent portfolio developments in 2025 are shaping competitive positioning in the PVP market?
• Which solubility enhancement or cosmetic trend is driving the next phase of growth?
• How is amorphous solid dispersion technology changing pharmaceutical PVP demand specifications?
• What role are clean beauty trends, pharmacopeia compliance, and biomass balance production playing in reshaping market dynamics?
• What demand-side drivers sustain growth, and how do they vary between pharmaceutical and industrial applications?

Market Definition

The polyvinylpyrrolidones (PVP) market covers water-soluble synthetic polymers in pharmaceutical, cosmetic, food, industrial, and adhesive grades used as tablet binders, film formers, stabilizers, dispersants, and solubilizers across powder, liquid, and solution forms in multiple molecular weight classes.

Market Inclusions

• Global and regional market size and forecasts for 2026 to 2036 across product, molecular weight, application, form, end use, and region.
• Demand analysis based on pharmaceutical manufacturing output, cosmetic production volumes, industrial adhesive consumption, and PVP excipient specifications.
• Competitive landscape including polymer portfolios, excipient validation, and manufacturing capabilities of leading companies.

Market Exclusions

• Polyvinylpyrrolidone-iodine (PVP-I) antiseptic products classified under pharmaceutical finished dosage forms.
• Other pharmaceutical excipients including cellulose derivatives, starch, and polyethylene glycol not based on PVP chemistry.
• Synthetic polymers unrelated to vinylpyrrolidone monomer chemistry.

Research Methodology

• Methodology combines secondary research from pharmaceutical excipient databases, polymer industry publications, and cosmetic ingredient catalogs with primary validation.
• Market sizing covers 30+ countries with inputs including pharmaceutical production, cosmetic manufacturing, industrial adhesive output, and PVP consumption per application.
• Primary validation includes more than 15 interviews with PVP manufacturers, pharmaceutical formulators, cosmetic companies, and industrial adhesive producers.